RARA CRAFT DATABASE for FDA Medical Devices

FDA Guidance and Notices, January 2026: Final Guidance on Clinical Decision Support Software and General Wellness

日本語版

January 2026 opened with two final guidance documents on January 6: one on clinical decision support (CDS) software and one on FDA's policy for low-risk general wellness products. Teams working on software should start there. FDA posted a CDS version with minor corrections on January 29, and on January 6 it also withdrew its 2017 guidance on clinical evaluation of software as a medical device (SaMD).

Among the drafts, the January 23 document on clinical performance testing for cuffless non-invasive blood pressure devices is the one device makers will feel directly. FDA began taking statements of interest for its TEMPO digital health pilot on January 2, and CDRH held a town hall on January 14 on the Quality Management System Regulation (QMSR).

RA Craft Database is an independent service and is not affiliated with or endorsed by the U.S. FDA. Articles are for general information on product development and regulatory research; they are not legal or regulatory advice for a specific device. Official FDA documents remain the authoritative source.

← All articles